5-(4-methylphenyl)-N-[(2S)-1,3,3-trimethyl-2-bicyclo[2.2.1]heptanyl]pyrazolo[5,1-f][1,6]naphthyridine-2-carboxamide
C28H30N4O — CID 155516555
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-(4-methylphenyl)-N-[(2S)-1,3,3-trimethyl-2-bicyclo[2.2.1]heptanyl]pyrazolo[5,1-f][1,6]naphthyridine-2-carboxamide
5-(4-methylphenyl)-N-[(2S)-1,3,3-trimethyl-2-bicyclo[2.2.1]heptanyl]pyrazolo[5,1-f][1,6]naphthyridine-2-carboxamide (PubChem CID 155516555) has the molecular formula C28H30N4O and a molecular weight of 438.58 g/mol. Its IUPAC name is 5-(4-methylphenyl)-N-[(2S)-1,3,3-trimethyl-2-bicyclo[2.2.1]heptanyl]pyrazolo[5,1-f][1,6]naphthyridine-2-carboxamide.
Molecular Properties
| Compound Name | 5-(4-methylphenyl)-N-[(2S)-1,3,3-trimethyl-2-bicyclo[2.2.1]heptanyl]pyrazolo[5,1-f][1,6]naphthyridine-2-carboxamide |
|---|---|
| PubChem CID | 155516555 |
| Molecular Formula | C28H30N4O |
| Molecular Weight | 438.58 g/mol |
| Exact Mass | 438.24 |
| IUPAC Name | 5-(4-methylphenyl)-N-[(2S)-1,3,3-trimethyl-2-bicyclo[2.2.1]heptanyl]pyrazolo[5,1-f][1,6]naphthyridine-2-carboxamide |
| SMILES | Cc1ccc(-c2cc3ncccc3c3cc(C(=O)N[C@H]4C5(C)CCC(C5)C4(C)C)nn23)cc1 |
| InChI | InChI=1S/C28H30N4O/c1-17-7-9-18(10-8-17)23-14-21-20(6-5-13-29-21)24-15-22(31-32(23)24)25(33)30-26-27(2,3)19-11-12-28(26,4)16-19/h5-10,13-15,19,26H,11-12,16H2,1-4H3,(H,30,33)/t19?,26-,28?/m1/s1 |
| InChIKey | GSERLXWNMBYDRB-YKJBCWCOSA-N |
| XLogP | 5.80 |
| TPSA | 59.29 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 438.58 |
| LogP ≤ 5 | 5.80 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155516555 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.